Sign in
Taking people in United StatesNo phase

TVMR With the INNOVALVE System Trial - Early Feasibility Study

Key facts

Who runs it
Edwards Lifesciences
Where
Ann Arbor, Atlanta, Chicago, Cleveland, Columbus, Detroit, Kansas City, Los Angeles, Manhasset, Morristown, Naples, Nashville, New York, Palo Alto, Philadelphia, Portland, Rochester, and Seattle, United StatesSee the 21 sites
Trial code
Status
Recruiting
People taking part
85 people, planned
Started
1 Sept 2022
Expected to end
1 Jul 2034
Type of study
Interventional
Treatments tested
  • INNOVALVE system
Record updated
21 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Clinically significant, symptomatic mitral regurgitation
  • High risk for open-heart surgery
  • Meets anatomical criteria

Who cannot take part

  • Unsuitable anatomy
  • Patient is inoperable
  • EF<25%

Where in United States

  • University of Michigan Hospital and Health SystemsAnn Arbor, United StatesContact: Keoni FordhamTaking people
  • Emory UniversityAtlanta, United StatesContact: Elizabeth CharlesTaking people
  • Piedmont Heart InstituteAtlanta, United StatesContact: Jennifer Bolivar AldanaTaking people
  • NorthwesternChicago, United StatesContact: BCVI Clinical Trials UnitTaking people
  • Cleveland ClinicCleveland, United StatesContact: Emily TylickiTaking people
  • OhioHealth Research InstituteColumbus, United StatesContact: Katy MonninTaking people
  • Henry Ford HealthDetroit, United StatesContact: Sahar RazmjouTaking people
  • Saint Luke's HospitalKansas City, United StatesContact: Brianna VannTaking people
  • Cedars SinaiLos Angeles, United StatesContact: Mitch GheorghiuTaking people
  • Northwell HealthManhasset, United StatesContact: Samantha AnnunziatoTaking people
  • Morristown Medical CenterMorristown, United StatesContact: Catherine Van ZileTaking people
  • Naples Comprehensive HealthNaples, United StatesContact: Kathy ByrdTaking people
  • Ascension Saint ThomasNashville, United StatesContact: Emily NormandinTaking people
  • Vanderbilt University Medical CenterNashville, United StatesContact: Kathy AdamsTaking people
  • CornellNew York, United StatesContact: TMTT ClinicalNo longer taking part
  • NewYork-Presbyterian / Columbia UniversityNew York, United StatesContact: TMTT ClinicalNo longer taking part
  • Stanford UniversityPalo Alto, United StatesContact: Anushka MaratheTaking people
  • University of PennsylvaniaPhiladelphia, United StatesContact: Kelli CookTaking people
  • Oregon Health & Science UniverstiyPortland, United StatesContact: Emmanuel Mills, MDTaking people
  • Mayo ClinicRochester, United StatesContact: Carl GriffinTaking people
  • Swedish Medical CenterSeattle, United StatesContact: Zaw Nu DanTaking people

About the trial

What the trial wants to find out

Study to evaluate the safety and performance of the INNOVALVE system

The group in the trial

  • TreatmentTreatment being tested

    MV replacement with INNOVALVE system

    Treatment: INNOVALVE system

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
21 September 2026